Cytokine and Chemokine protein levels in the SNpc following Nurr1 agonist treatment.
<p><sup>a</sup> Cytokines and chemokine levels in the SN (pg/mg), analyzed by multiplex ELISA</p><p><sup>b</sup> Data is represented as mean ± SEM and significance is annotated as *p<0.05</p><p>Cytokine and Chemokine protein levels in the SNpc following Nurr1 agonist treatment.</p
Biological Sciences, Nurr 1 agonist treatment causes neuroprotective, dat, microglial morphology, proinflammatory cytokines, snpc, vmat, substantia nigra pars compacta, dopamine neuron degeneration model, novel Nurr 1 agonist, Nurr 1, dopamine synthesis, inflammation, pd, Daily gavage treatment, neuroprotective effects, il, OHDA, GFAP staining intensity, dopaminergic neurons, Nurr 1 expression, aadc, dopaminergic target genes, SA 00025, 32 days, sn, iba, Nurr 1 Agonist Causes Neuroprotection, dopaminergic neuron degeneration, dopaminergic phenotype genes TH, staining intensity, gdnf
DOI identifier: 10.1371/journal.pone.0121072.t001
Sorry, we are unable to provide the full text but you may find it at the